Clinical TrialsSearch results
Number of results: 198
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Human Vitreous Concentration of Brimonidine after Instillation of Ailamide Combination Ophthalmic Suspension
- Idiopathic epiretinal membrane, macular hole
- Inatani Masaru
- 2020-11-25
Completed
- Investigation on the Efficacy and Safety of the Combination Therapy of Prostaglandin Analogs and Brimonidine/Timolol Fixed Combination
- Open angle glaucoma (primary open angle glaucoma or exfoliation glaucoma), ocular hypertension
- Inatani Masaru
- 2020-03-27
Completed
- Investigational research of an automatic control of vasoactive drug and infusion volume
- Patients with ASA physical status of 1 and 2, scheduled for surgery under total intravenous anesthes
- Matsuki Yuka
- 2023-10-27
Completed
- PMS-1 exploratory Investigator Initiated clinical trial
- atients scheduled to undergo surgery under general anesthesia
- Nakai Kunihiro
- 2020-06-08
Completed
- Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF (PULSED AF)
- drug refractory recurrent symptomatic paroxysmal or persistent atrial fibrillation
- Shiomitsu Aki
- 2021-06-10
Completed
- Research for automatic control of infusion volume
- Patients with ASA physical status of 1 and 2, scheduled for surgery under total intravenous anesthes
- Matsuki Yuka
- 2023-01-05
Completed
- Study on the Safety and Immunogenicity of a Live-Attenuated Respiratory Syncytial Virus Vaccine in Children 6 to < 24 Months of Age in Japan
- Healthy children
- Tanaka Tomoyuki
- 2023-04-29
Recruiting
- [F-18]NaF-PET for bone imaging
- metastatic bone tumor
- Okazawa Hidehiko
- 2023-07-08
Recruiting
- A Modular Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD9829 as Monotherapy or in Combination in Patients With CD123-Positive Hematological Malignancies
- Hematological Malignancies
- Hibi Kazushige
- 2024-02-15
Recruiting
- A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
- Asthma
- Jared Silver
- 2024-05-27